Incline Therapeutics - Top 15 Biotech VC Deals of 2010

Company: Incline Therapeutics
Based: Redwood City, CA
Amount: $43M

Investors: Frazier Healthcare Ventures, 5AM Ventures, Technology Partners, Adams Street Partners, Saints Capital and Emergent Medical Partners

Scoop: In June, Incline closed a $43 million Series A funding round, as well as $3.5 million upfront for a potential buyout from Cadence Pharmaceuticals. The company, which is focusing on its needle-free pain med delivery device Ionsys, could be worth up to $228 million to Cadence--depending on when the deal goes through--plus another $57 million if Ionsys receives FDA approval.

Incline Therapeutics - Top 15 Biotech VC Deals of 2010

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.